Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pasalix vs Valeriana in Mild to Moderate Anxiety
NCT00794456Phase 3Completed
- Start
- Sep 2009
- Primary completion
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of passiflora incarnata + crataegus oxyacantha + salix alba in generalized anxiety disorder (GAD) (2 arms). Primary endpoint: Hamilton Anxiety Scale at 6 weeks. Started Sep 2009; status: completed.
02
Drugs
passiflora incarnata + crataegus oxyacantha + salix alba
03
Conditions
generalized anxiety disorder (GAD)
Beyond the preview
Go deeper on NCT00794456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00794456.